AMENDMENT NO. 2 to EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 23rd, 2015 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 2 (this “Amendment No. 2”), dated as of June 15, 2015, is entered into between Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute, a Washington non-profit corporation (“Licensor”) and Juno Therapeutics, Inc., a Delaware corporation (“Licensee”).
